Oct 20 (Reuters) - Elos Medtech AB ELOSSb.ST :
* ELOS MEDTECH INTERIM REPORT JANUARY 1 - SEPTEMBER 30, 2021
* NET SALES FOR Q3 AMOUNTED TO SEK 187.2 (147.9) MILLION, AN
INCREASE OF 26.6 PERCENT COMPARED TO SAME PERIOD LAST YEAR.
* Q3 OPERATING PROFIT FOR YEAR WAS SEK 24.2 (17.9) MILLION,
CORRESPONDING TO AN OPERATING MARGIN OF 12.9 (12.1) PERCENT
* Q3 PROFIT AFTER NET FINANCIAL ITEMS AMOUNTED TO SEK 23.3
(14.2)
MILLION.
* Q3 DEVELOPED WELL AND SALES GROWTH FOR QUARTER WAS 27
PERCENT
COMPARED TO A COVID-AFFECTED WEAK QUARTER IN 2020
* ALL BUSINESS AREAS REPORTED STRONG SALES AND EARNINGS
Source text for Eikon: ID:nWkrWfj
Further company coverage: ELOSSb.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))